A comparison of urinary 17-hydroxycorticosteroid and 11-deoxy-17-oxosteroid excretion in obesity, in thyroid dysfunction and in early breast cancer.
作者信息
Sneddon A, Steel J M, Strong J A
出版信息
J Endocrinol. 1969 Feb;43(2):48-9.
PMID:4237784
Abstract
摘要
相似文献
1
2
Effect of thyroid funtion and of obesity on discriminant function for mammary carcinoma.甲状腺功能和肥胖对乳腺癌判别函数的影响。
Lancet. 1968 Oct 26;2(7574):892-4. doi: 10.1016/s0140-6736(68)91056-8.
3
A comparative study of the urinary excretion of glucocorticoids and 11-deoxy-17-ketosteroids in a group of obese women.
Ann Endocrinol (Paris). 1974 Jul-Aug;35(4):508-20.
4
Excretion of urinary 17-hydroxycorticosteroids and 11-deoxy-17-oxosteroids by women using steroidal contraceptives.使用甾体避孕药的女性尿中17-羟皮质类固醇和11-脱氧-17-氧类固醇的排泄情况。
Lancet. 1969 Nov 15;2(7629):1033-5. doi: 10.1016/s0140-6736(69)90642-4.
5
The relationship of urinary androgen metabolites to breast diseases including carcinoma.尿雄激素代谢产物与包括癌在内的乳腺疾病的关系。
Mt Sinai J Med. 1974 Sep-Oct;41(5):682-6.
6
Benign and malignant breast disease in South Wales: a study of urinary steroids.南威尔士的乳腺良性与恶性疾病：尿甾体类激素研究
Br Med J. 1970 Dec 26;4(5738):768-71. doi: 10.1136/bmj.4.5738.768.
7
Effect of age, obesity, starvation, and changes in adrenocortical and ovarian activity on the urinary excretion of dehydroepiandrosterone relative to androsterone plus etiocholanolone: relevance to the measurement of breast cancer discriminants in women.
Clin Biochem. 1974 Jun;7(2):119-30. doi: 10.1016/s0009-9120(74)91218-1.
8
[The mechanism of action of hydrocortisone administered by lumbar puncture in breast cancer].[腰椎穿刺注射氢化可的松治疗乳腺癌的作用机制]
Vopr Onkol. 1973;19(9):19-23.
9
The urinary excretion of 11-deoxy-17-oxosteroids and 17-hydroxycorticosteroids by normal Japanese and British women.
J Endocrinol. 1967 Aug;38(4):401-6. doi: 10.1677/joe.0.0380401.
10
Hormonal influences in breast cancer.乳腺癌中的激素影响。
Proc R Soc Med. 1971 May;64(5):509-16. doi: 10.1177/003591577106400524.
Zotero 插件